Table.

Cell Viability as a Percentage of Control^a

	Mean ± SD
	MTT			LDH			ATPlite
Formulation Tested	1 Min	5 Min	30 Min	1 Min	5 Min	30 Min	1 Min	5 Min	30 Min
Medium (control)	102.1 ± 2.12	101.5 ± 2.12	100.1 ± 2.12	1.015 ± 0.02	1.012 ± 0.01	1.010 ± 0.01	101.0 ± 1.73	100.0 ± 1.23	101.5 ± 2.12
LB-VD	90.67 ± 0.57	88.59 ± 0.37	88.21 ± 2.04	1.025 ± 0.03	1.477 ± 0.02	1.348 ± 0.07	91.55 ± 1.22	88.10 ± 1.40	90.60 ± 1.12
TA-PF	67.88 ± 0.77	71.47 ± 5.13	70.68 ± 1.41	1.323 ± 0.04	2.024 ± 0.04	1.407 ± 0.03	83.00 ± 2.08	80.21 ± 1.47	83.80 ± 1.55
D-TA-BA	59.29 ± 6.93	61.96 ± 5.34	43.98 ± 3.53	1.359 ± 0.07	1.905 ± 0.11	1.684 ± 0.09	59.76 ± 1.32	54.61 ± 7.11	59.87 ± 2.82
TA-BA	56.41 ± 6.76	56.39 ± 4.19	29.38 ± 2.82	2.115 ± 0.02	2.935 ± 0.04	3.330 ± 0.21	38.17 ± 7.46	39.14 ± 5.87	42.25 ± 2.82

^aThe MTT, LDH, and ATPlite assays were used to measure cell metabolic activity and LDH and ATP levels in ARPE-19 cells.